Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Insiders ranked
342
Showing 50 of 342
Quality filters
10+ trades
≥3 issuers, 50% price coverage
Window
5y trailing
Trade date filter
| # | Insider | Trades | Issuers | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|
| 51 | Baker Julian | 10/18 | 3 | 40% | +22.3% | -10.4% | +88.8% | -27.0% |
| 52 | Baker Bros. Advisors (Gp) LLC | 10/18 | 3 | 40% | +22.3% | -10.4% | +88.8% | -27.0% |
| 53 | Wallman Richard F | 12/15 | 4 | 75% | +22.1% | +25.1% | +45.1% | -1.7% |
| 54 | Rocklage Scott M | 26/32 | 5 | 69% | +21.7% | +37.8% | +79.2% | -53.1% |
| 55 | Vassalluzzo Scott J | 25 | 3 | 100% | +21.5% | +17.8% | +50.1% | +5.7% |
| 56 | Sb Investment Advisers (UK) Ltd | 123/124 | 5 | 76% | +21.3% | +49.0% | +68.9% | -87.4% |
| 57 | Orbimed Capital Gp VII LLC | 43/79 | 6 | 74% | +20.3% | +35.9% | +76.5% | -53.2% |
| 58 | Kolchinsky Peter | 78/102 | 6 | 77% | +20.3% | +3.2% | +80.4% | -13.6% |
| 59 | Ra Capital Management, L.P. | 78/102 | 6 | 77% | +20.3% | +3.2% | +80.4% | -13.6% |
| 60 | Ra Capital Healthcare Fund LP | 78/102 | 6 | 77% | +20.3% | +3.2% | +80.4% | -13.6% |
| 61 | Shah Rajeev M. | 78/102 | 6 | 77% | +20.3% | +3.2% | +80.4% | -13.6% |
| 62 | Prescott General Partners LLC | 29 | 3 | 93% | +19.4% | +17.8% | +50.1% | -12.3% |
| 63 | Goldman Sachs & Co. LLC | 52/63 | 12 | 56% | +19.3% | +17.9% | +96.9% | -44.3% |
| 64 | Goldman Sachs Group Inc | 52/82 | 13 | 56% | +19.3% | +17.9% | +96.9% | -44.3% |
| 65 | Blackstone Holdings II L.P. | 46/88 | 9 | 83% | +19.0% | +18.8% | +55.4% | -26.1% |
| 66 | Chu Chinh | 31/36 | 3 | 94% | +18.6% | +9.7% | +59.9% | -1.8% |
| 67 | Deerfield Management Company, L.P. (Series C) | 25 | 4 | 80% | +18.3% | +24.0% | +36.9% | -3.5% |
| 68 | Deerfield Mgmt IV, L.P. | 25 | 4 | 80% | +18.3% | +24.0% | +36.9% | -3.5% |
| 69 | Deerfield Private Design Fund IV, L.P. | 25 | 4 | 80% | +18.3% | +24.0% | +36.9% | -3.5% |
| 70 | Flynn James E | 25 | 4 | 80% | +18.3% | +24.0% | +36.9% | -3.5% |
| 71 | Blackstone Holdings I/II Gp L.L.C. | 66/110 | 11 | 80% | +18.0% | +18.8% | +55.4% | -26.1% |
| 72 | Smith Thomas W | 29 | 3 | 90% | +18.0% | +17.8% | +50.1% | -11.6% |
| 73 | Orbimed Capital LLC | 16 | 3 | 100% | +18.0% | +10.1% | +48.1% | +0.8% |
| 74 | Pacific Investment Management Co LLC | 27 | 3 | 52% | +16.1% | +2.6% | +83.1% | -25.7% |
| 75 | Plp Funds Master Fund LP | 14 | 5 | 50% | +15.9% | +2.2% | +66.3% | -56.1% |
| 76 | Yamamoto Mika | 21/22 | 3 | 86% | +15.8% | +18.6% | +38.6% | -14.1% |
| 77 | Meresman Stanley J | 20 | 3 | 85% | +15.8% | +26.0% | +49.0% | -45.1% |
| 78 | Graves Gregory B | 27/29 | 4 | 63% | +14.5% | +21.9% | +78.3% | -21.3% |
| 79 | Lindstrom Carol | 10 | 3 | 90% | +14.5% | +15.7% | +36.9% | -5.9% |
| 80 | Lampert Edward S | 89/90 | 3 | 67% | +14.4% | +7.1% | +55.3% | -52.9% |
| 81 | Tompkins Mark N. | 37/68 | 4 | 86% | +13.7% | +23.9% | +36.5% | -66.0% |
| 82 | Blackstone Holdings I L.P. | 22/24 | 3 | 68% | +13.7% | +16.7% | +25.6% | -5.6% |
| 83 | Wendling Brian J | 14/28 | 4 | 50% | +13.5% | +0.0% | +85.3% | -15.3% |
| 84 | Sandell Scott D | 44/71 | 9 | 64% | +13.5% | +11.2% | +60.2% | -24.8% |
| 85 | Edelman Joseph | 20/23 | 4 | 60% | +12.9% | +80.9% | +85.1% | -267.6% |
| 86 | Perceptive Advisors LLC | 20/23 | 4 | 60% | +12.9% | +80.9% | +85.1% | -267.6% |
| 87 | Perceptive Life Sciences Master Fund Ltd | 20/23 | 4 | 60% | +12.9% | +80.9% | +85.1% | -267.6% |
| 88 | Parmar Kush | 30/34 | 4 | 60% | +12.6% | +30.4% | +79.2% | -69.2% |
| 89 | Schwab Andrew J. | 30/40 | 6 | 60% | +12.6% | +30.4% | +79.2% | -69.2% |
| 90 | Fmr LLC | 14/24 | 4 | 86% | +12.4% | +20.0% | +27.9% | -53.6% |
| 91 | Orbimed Advisors LLC | 123/196 | 20 | 63% | +12.1% | +13.8% | +76.5% | -109.7% |
| 92 | Fust Matthew K | 10 | 3 | 30% | +11.0% | -9.6% | +96.2% | -18.6% |
| 93 | Ccmp Capital Associates III Gp, LLC | 30 | 3 | 77% | +10.8% | +5.8% | +37.6% | -19.9% |
| 94 | Ccmp Capital Associates III, L.P. | 30 | 3 | 77% | +10.8% | +5.8% | +37.6% | -19.9% |
| 95 | Ccmp Capital Gp, LLC | 30 | 3 | 77% | +10.8% | +5.8% | +37.6% | -19.9% |
| 96 | Ccmp Capital Investors III (Employee), L.P. | 30 | 3 | 77% | +10.8% | +5.8% | +37.6% | -19.9% |
| 97 | Ccmp Capital Investors III, L.P. | 30 | 3 | 77% | +10.8% | +5.8% | +37.6% | -19.9% |
| 98 | Dell Michael S | 91/92 | 3 | 85% | +10.6% | +12.1% | +32.1% | -13.9% |
| 99 | Trian Fund Management, L.P. | 21/23 | 3 | 100% | +10.2% | +11.8% | +17.4% | +0.2% |
| 100 | Ccmp Capital, LP | 37 | 3 | 81% | +9.7% | +5.1% | +37.6% | -19.9% |